Saxagliptin, a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus: novel aspects

被引:0
作者
Pedrianes Martin, P. [1 ]
de Pablos Velasco, P. L. [1 ]
机构
[1] Hosp Univ Dr Negrin, Dept Endocrinol & Nutr, Las Palmas Gran Canaria, Spain
来源
AVANCES EN DIABETOLOGIA | 2010年 / 26卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:446 / 448
页数:3
相关论文
共 13 条
[1]  
Agencia Europea del Medicamento, ONGL EPAR INF
[2]  
Boulton DW, 2009, CLIN PHARMACOL THER, V85, pS96
[3]   Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial [J].
Chacra, A. R. ;
Tan, G. H. ;
Apanovitch, A. ;
Ravichandran, S. ;
List, J. ;
Chen, R. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (09) :1395-1406
[4]   The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone [J].
DeFronzo, Ralph A. ;
Hissa, Miguel N. ;
Garber, Alan J. ;
Gross, Jorge Luiz ;
Duan, Raina Yuyan ;
Ravichandran, Shoba ;
Chen, Roland S. .
DIABETES CARE, 2009, 32 (09) :1649-1655
[5]   Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis [J].
Drucker, DJ .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (02) :161-171
[6]   PLASMA INSULIN RESPONSE TO ORAL + INTRAVENOUS GLUCOSE ADMINISTRATION [J].
ELRICK, H ;
HLAD, CJ ;
ARAI, Y ;
STIMMLER, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1964, 24 (10) :1076-+
[7]   A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes [J].
Frederich, Robert ;
Alexander, John H. ;
Fiedorek, Fred T. ;
Donovan, Mark ;
Berglind, Niklas ;
Harris, Susan ;
Chen, Roland ;
Wolf, Robert ;
Mahaffey, Kenneth W. .
POSTGRADUATE MEDICINE, 2010, 122 (03) :16-27
[8]   Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone [J].
Hollander, Priscilla ;
Li, Jia ;
Allen, Elsie ;
Chen, Roland .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) :4810-4819
[9]  
International Diabetes Federation, 2006, THE DIAB ATL
[10]   Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial [J].
Jadzinsky, M. ;
Pfuetzner, A. ;
Paz-Pacheco, E. ;
Xu, Z. ;
Allen, E. ;
Chen, R. .
DIABETES OBESITY & METABOLISM, 2009, 11 (06) :611-622